Steven M Gauze, ARNP Clinical Nurse Specialist - Family Health Medicare: Accepting Medicare Assignments Practice Location: 2160 Blacklog Rd, Suite 120, Inez, KY 41224 Phone: 606-298-7405 Fax: 606-298-3284 |
News Archive
A two-year, multi-center clinical study with 167 patients with class III-IV refractory angina randomized to low and high dose CD34+ cells or placebo has revealed that patients who received either a high or low dose of CD34 - a member of a family of proteins that have an impact on vascular-associated tissue - cells had a significant reduction in angina frequency over patients who received placebo.
Mayo Clinic Cancer Center has announced that a multiple myeloma clinical trial has shown a significant improvement in survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone.
The UCLA School of Public Health today announced a $10 million grant from the National Institutes of Health to fund a Center for Population Health and Health Disparities in partnership with the University of Southern California, the Los Angeles County Department of Public Health and several community collaborators.
Mylan Laboratories has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Glipizide and Metformin Hydrochloride Tablets in 2.5 mg/250 mg, 2.5 mg/500 mg and 5 mg/500 mg strengths.
› Verified 3 days ago